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Abstract
Background: Leukotriene B4 (LTB4) is a potent inflammatory mediator that also stimulates the
immune response. In addition, it promotes polymorphonuclear leukocyte phagocytosis,
chemotaxis, chemokinesis and modulates cytokines release. Regarding chemical instability of the
leukotriene molecule, in the present study we assessed the immunomodulatory activities conferred
by LTB4 released from microspheres (MS). A previous oil-in-water emulsion solvent extraction-
evaporation method was chosen to prepare LTB4-loaded MS.
Results: In the mice cremasteric microcirculation, intraescrotal injection of 0.1 ml of LTB4-loaded
MS provoked significant increases in leukocyte rolling flux, adhesion and emigration besides
significant decreases in the leukocyte rolling velocity. LTB4-loaded MS also increase peroxisome
proliferator-activated receptor-α (PPARα) expression by murine peritoneal macrophages and
stimulate them to generate nitrite levels. Monocyte chemoattractant protein-1 (MCP-1) and nitric
oxide (NO) productions were also increased when human umbilical vein and artery endothelial
cells (HUVECs and HUAECs, respectively) were stimulated with LTB4-loaded MS.
Conclusion: LTB4-loaded MS preserve the biological activity of the encapsulated mediator
indicating their use as a new strategy to modulate cell activation, especially in the innate immune
response.
Background
Leukotriene B4 (LTB4), a 5-lipoxygenase (5-LO)-derived
eicosanoid acts as a potent chemoattractant for polymor-
phonuclear neutrophils (PMNs) [1], eosinophils [2] and
effector T cells [3]. In addition to its direct impact on leu-
kocyte effector functions, leukotrienes also promote
innate immune responses indirectly by stimulating the
production of other inflammatory mediators [4,5], induc-
ing phagocytosis [6] and activating antimicrobial mecha-
nisms [7,8]. Recent studies in animal models have shown
that endogenous leukotrienes display protective effect
against infectious diseases, including bacterial peritonitis
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[9], fungal pneumonia [4] and infections caused by
helminths [5]. LTB4 binds to and activates its high-affinity
receptor BLT1, which can be localized on neutrophils,
eosinophils, monocytes [10] and T cells [11]. Other spe-
cific receptors for LTB4 are the so-called peroxisome prolif-
erator-activated receptors (PPARs), which are situated in
the cell nucleus. PPARs have been reported to regulate
inflammatory responses, both in vivo and in vitro. In this
context, PPARα activation by LTB4 binding affects the
duration of the inflammatory response induced by this
eicosanoid [12].
Regarding leukocyte recruitment, chemoattractants bind
to their receptors on leukocytes, thereby converting roll-
ing to firm adhesion via rapid integrin activation and/or
up-regulation [13,14]. Flow cytometry studies have dem-
onstrated that LTB4 triggers the up-regulation of β2-
integrins on neutrophil and monocyte surface [15,16].
Several studies have suggested that lipoxygenase-triggered
leukocyte adhesion might actually be due in large part to
direct effects on human endothelial cells, although the rel-
evant adhesive mechanisms have yet to be characterized
[17-19]. Thus, the mechanisms by which LTB4 contributes
to leukocyte activation and recruitment are not clearly
defined.
On the other hand, previous studies have reported that
LPS, TNF-α, IL-1β and LTB4 itself, differentially increase
the expression of BLT1 and/or BLT2 receptors on HUVECs
[20]. In addition, in human coronary artery, LTB4 also
induces two important physiological responses, chemo-
taxis and proliferation [21]. Moreover, as demonstrated
by intravital microscopy studies, LTB4 was very active in
the microcirculation and promoted the adhesion of leu-
kocytes to the endothelium, followed by diapedesis and
migration into tissue [3]. Although it has been reported
that LTB4 can induce CD54 (ICAM-1) expression in
endothelial cells [22,23], the prevailing notion is that
adhesive and migratory effects of this mediator are prima-
rily originated from its action on the leukocyte, where che-
moattractants induce up-regulation of cell-adhesion
molecules that can interact with their cognate receptors on
endothelial cells [24,25].
The aim of this study was to assess the activity of encapsu-
lated LTB4 during in vitro and in vivo assays. In this regard,
different studies have shown that systems that control
antigen release can increase specific immunity by selec-
tively driving an antigen or gene vector to immune effec-
tors cells [26]. Based on the successful encapsulation of
the LTB4 molecule [27] the proposed formulation can be
employed on its own or combined with other therapies
for the treatment of inflammatory diseases since LTB4 can
act as immunomodulator during the inflammatory
response. Other applications for this technology include
the use of biodegradable polymer systems, which allow
the sustained and controlled release of the encapsulated
substances [28,29]. Therefore, in this study, we have eval-
uated the effect of LTB4-loaded microspheres (MS) on leu-
kocyte-endothelial cell interactions in the murine
cremasteric microcirculation. In addition, we have also
investigated the effect of LTB4 released from microspheres
in inducing MCP-1 release and nitrites production by
mouse peritoneal macrophages, HUVECs and HUAECs.
Moreover, in order to elucidate different mechanisms of
cell activation after LTB4-loaded MS engulfment we
assessed PPARα expression under the effect of the media-
tor released inside the cell, exclusively.
Methods
Materials
For the purposes of this study, the LTB4 solution, LPS of E.
coli (serotype 0127:B8), polyvinyl alcohol, tribromoetha-
nol and Griess reagent mixtures were obtained from
Sigma Chemical Co. (St. Louis, MO, USA). Poly-lactic
coglycolic acid (PLGA) polymer (50:50) was obtained
from Boehringer Ingelheim (Ingelheim, Germany). Meth-
anol, methylene dichloride, acetonitrile and acetic acid
(high-performance liquid chromatography grade) were
purchased from Merck (Dietikon, Switzerland). Endothe-
lial basal medium (EBM)-2 supplemented with endothe-
lial growth media (EGM)-2 were from Clonetics,
Barcelona, Spain. The chemokine and the antibody pair
for human human MCP-1 ELISA was from R&D Systems,
Madrid, Spain. Neutravidin-horseradish peroxidase was
from Perbio Science, Cheshire, UK. K-Blue substrate was
from Neogen, Lexington, KY. The specific BLT1 receptor
antagonist CP-105,696 was a kind gift from Pfizer, Inc.
(Indianapolis, IN, USA).
Ethical approval
Intravital microscopy studies with C57BL/6J mice from
Charles River, weighting 23–30 g were approved by the
Institutional Animal Care and Use Committee of the Fac-
ulty of Medicine, University of Valencia (Spain) and were
conducted humanely.
Six- to eight-week old 5-LO-/- (129-Alox5tm1Fun) and
strain-matched wild-type (WT) male sv129 mice were
obtained from Jackson Laboratories, and were bred in the
Faculdade de Ciências Farmacêuticas de Ribeirão Preto,
Universidade de São Paulo, Brasil. All experiments were
approved and conducted in accordance with the guide-
lines of the Animal Care Committee of the University of
São Paulo, Brazil. Mice were maintained under standard
laboratory conditions.
Preparation and characterization of the microspheres
Microspheres (MS) (diameters between 5 and 6 μm) con-
taining LTB4 were prepared using an oil-in-water emul-
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sion solvent extraction-evaporation process [27]. In brief,
0.3 ml internal organic phase (LTB4 3 × 10-5 M, dissolved
in ethanol) was added to 10 ml of methylene dichloride
containing 30 mg of PLGA 50:50. This phase was poured
into an external aqueous phase (40 ml of polyvinyl alco-
hol solution at 3% w/v) and stirred mechanically (RW20;
IKA Labortechnik, Staufen, Germany) at 600 rpm for 4 h
to extract the organic solvent. Finally, the microspheres
formed were washed three times with doubly distilled
water and then freeze-dried. All the assays were conducted
with previously characterized microspheres.
Administration of the microspheres in the mouse lungs
5-LO-/- mice were anesthetized with 2.5% tribromoetha-
nol and restrained on a small board. An anterior midline
incision was made for trachea exposition. A 30-gauge nee-
dle attached to a tuberculin syringe was inserted into the
trachea, and intratracheal (i.t.) dispersion was used to
introduce 0.1 ml of PBS, LTB4 in solution (3 × 10-8 M),
unloaded and LTB4-loaded MS (5 × 10-7 M or 160 ng/ml)
into the lungs. PBS was the vehicle for all administrations.
Histology
For representative histological sections that could show
leukocyte infiltration in the lung parenchyma, lungs were
removed on day 7 after the stimuli administrations. Then,
the tissues were fixed in 10% formalin and embedded in
paraffin blocks. Lung sections (5 μm) are representative of
three experiments with 5-LO-/- mice (5 animals each
group) and were stained with hematoxylin and eosin
(HE). Analysis of the sections was performed in a
"blinded" manner.
Intravital microscopy
The mouse cremaster preparation used in this study was
similar to that described previously [30]. Mice were anes-
thetized by i.p. injection with a mixture of xylazine hydro-
chloride (10 mg/kg) and ketamine hydrochloride (200
mg/kg). A polyethylene catheter was placed in the jugular
vein to permit the intravenous administration of addi-
tional anesthetic. The cremaster muscle was dissected free
of tissues and exteriorized onto an optical clear viewing
pedestal. The muscle was cut longitudinally with a cautery
and held flat against the pedestal by attaching silk sutures
to the corners of the tissue. The muscle was then perfused
continuously at a rate of 1 ml/min with warmed bicarbo-
nate-buffered saline (pH 7.4).
The cremasteric microcirculation was then observed by
using an intravital microscope (Nikon Optiphot-2, SMZ1,
Badhoevedorp, The Netherlands) equipped with a 20×
objective lens (Nikon SLDW, Badhoevedorp, The Nether-
lands) and a 10× eyepiece. A video camera (Sony SSC-
C350P, Koeln, Germany) mounted on the microscope
projected the image onto a color monitor and the images
were video recorded for playback analysis. Single
unbranched cremasteric venules (20–40 μm in diameter)
were selected for study and the diameter was measured
on-line by using a video caliper (Microcirculation
Research Institute, Texas A&M University, College Station,
Texas). Centerline red blood cell velocity (Vrbc) was also
measured on-line by using an optical Doppler velocimeter
(Microcirculation Research Institute, Texas A&M Univer-
sity, College Station, Texas). Venular blood flow was cal-
culated from the product of mean red blood cell velocity
(Vmean = Vrbc/1.6) and cross sectional area, assuming cylin-
drical geometry. Venular wall shear rate (γ) was calculated
based on the Newtonian definition: γ = 8 × (Vmean/Dv) s-1,
in which Dv is venular diameter [31].
The number of rolling, adherent and emigrated leukocytes
was determined off-line during playback of videotaped
images. Rolling leukocytes were defined as those white
blood cells moving at a velocity less than that of erythro-
cytes in the same vessel. Leukocyte rolling velocity (Vwbc)
was determined from the time required for a leukocyte to
move along 100 μm length of the microvessel and is
expressed as μm/s. Flux of rolling leukocytes was meas-
ured as those cells that could be seen moving past a
defined reference point in the vessel. The same reference
point was used throughout the experiment because leuko-
cytes may roll for only a section of the vessel before rejoin-
ing the blood flow or becoming firmly adherent. A
leukocyte was defined as adherent to venular endothe-
lium if it was stationary for at least 30 s. Leukocyte adhe-
sion was expressed as the number per 100 μm length of
venule. Leukocyte emigration was expressed as the
number of white blood cells per microscopic field sur-
rounding the venule.
Experimental protocol
All preparations were left to stabilize for 30 minutes. Ani-
mals were injected locally by s.c. injection beneath the
scrotal skin using a 30-gauge needle with 0.1 ml (each tes-
ticle) of sterile saline, LPS (0.05 μg/kg), unloaded or LTB4-
loaded microspheres (1 mg/ml, containing equivalent to
50 ng/ml of the solution form) and LTB4 in solution (200
ng/ml). Preliminary experiments indicated that local
administration of 0.05 μg/kg LPS was optimal for exami-
nation of leukocyte-endothelial interaction [32]. Animals
were returned to their cages for 3.5 h and the right cremas-
ter muscle was then prepared for intravital microscopy.
After 4 h of the intraescrotal injection of the agents under
investigation, measurements of leukocyte rolling flux,
velocity, adhesion, emigration, Vrbc,, shear rate and diam-
eter were obtained and recorded for 5 min.
Cell isolation and culture
Human umbilical vein and artery endothelial cells
(HUVECs and HUAECs, respectively) were isolated by
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collagenase treatment [33] and maintained in human
endothelial cell-specific EBM-2 supplemented with EGM-
2 and 10% fetal calf serum (FCS). Cells up to passage 2
were grown to confluence on 24-well culture plates.
Before every experiment, cells were incubated for 16 hours
in medium containing 1% FCS and then returned to the
10% FCS medium for all experimental incubations. Sam-
ples of LTB4 in solution (200 ng/ml) and unloaded or
LTB4-loaded microspheres (1 mg/ml, containing equiva-
lent to 50 ng/ml of the solution form) were added to
wells. At the end of an incubation time of 4 h, cell-free
supernatants were collected and stored at -20°C for MCP-
1 ELISA and NO measurement by Griess reaction.
Mice peritoneal macrophages were harvested from killed
mice (sv129 mice) by lavage of their peritoneal cavity with
3 ml of RPMI-1640 medium. The isolated cells were cen-
trifuged at 400 g for 10 min and re-suspended to 3 × 106
cells/ml. Aliquots (0.5 ml) of cell suspension were added
to the wells of a 24-well plate and placed overnight in a
humidified atmosphere (37°C, 5% CO2) for cell adhe-
sion. Non-adherent cells were removed by washing with
RPMI-1640 medium with 10% of fetal bovine serum
(FBS) and gentamycin (1 μl/ml). Firmly adhering cells (5
× 106 cells/well) were incubated for 4 h with LTB4 in solu-
tion (5 × 10-8 M) in the absence or presence of CP 105,696
(5 × 10-8 M), a specific BLT1 receptor antagonist. Simi-
larly, cells were incubated with unloaded or LTB4-loaded
MS (1 mg/ml, containing equivalent to 50 ng/ml of the
solution form) in the absence or presence of CP 105,696.
At the end of the incubation period, cell-free supernatants
were collected and stored at -20°C for NO measurement
by Griess reaction.
PPAR-alpha expression assay
After 4 h incubation with the stimuli described above,
peritoneal macrophages (5 × 106 cells/well) were homog-
enized in lysis buffer (25 mM TrisHCl pH 7.6, 150 mM
NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS),
which contained a protease inhibitor cocktail and 100
mM PMSF, (all from Sigma, Heidelberg, Germany). After
scrapping the cells they were centrifuged for 5 min, 10000
rpm at 4°C. Protein concentration was determined by
using a bicinchoninic acid (BCA) protein assay kit
(Pierce). Equal amounts (30 μg/lane) of protein were sub-
jected to SDS-PAGE (10% (w/v)) gel and separated pro-
teins were electroblotted on polyvinylidene difluoride
(PVDF) membranes (Bio-Rad Laboratories). Western
analysis was performed with antibodies against PPARα
(ab8934) (Abcam Cambridge Science Park, Cambridge,
UK) and β-actin (Sigma Aldrich).
Densitometry
Densitometric analyses of autoradiograms were per-
formed [34]. For each immunoblot, the pixel density
I.O.D. (integrated optical density) was determined by
selecting a rectangle of identical surface for all determina-
tions, designed to entirely cover the band of interest. Back-
ground, which was subtracted from all values, was
obtained using an average value from a clear area of the
autoradiogram and all pixels at a black value of 255.
Results were expressed as an Index = I.O.D. of stimulated
cells/I.O.D. of cells cultured in medium alone.
NO production by HUVECs, HUAECs and murine 
macrophages
NO production by human endothelial cells and murine
macrophages was determined by Griess reaction.
HUVECs, HUAECs and peritoneal macrophages were
incubated for 4 h with the described stimuli above. Super-
natants (0.1 ml) were incubated with an equal volume of
Griess reagent mixtures (1% sulfanilamine, 0.1% N-(1-
naphtyl)-ethylendiamine dihydrochloride, 2.5% H3PO4)
at room temperature for 10 min. The absorbance was
measured in a microplate reader at 540 nm and concen-
trations calculated from a sodium nitrite standard curve.
Data are presented as micromoles of NO2- (nitrite) (mean
± the SEM).
MCP-1 release from HUVECs and HUAECs
Human endothelial cells were cultured in 24-well culture
plates and stimulated as described. After coating the 96-
well plates overnight with the coating anti-MCP-1 mAb,
diluted supernatant samples and standards were added in
PBS/0.5% BSA/0.05% sodium azide for 2 h. Biotinylated
detector antibodies were added for 2 h, followed by neu-
travidin-horseradish peroxidase for 1 h. All plate washes
were of four cycles in freshly made PBS/0.2% Tween 20.
Enhanced K-Blue TMB substrate was added for 30 min
and the enzyme reaction stopped by addition of 0.19 M
sulphuric acid. Absorbance was read at 450 nm and the
data processed by GraphPad Prism software. Results are
expressed as pM chemokine in the supernatant. The sensi-
tivity of the assay was > 10 pg/ml.
Statistical analysis
The assays were analyzed using One-way analysis of vari-
ance (ANOVA) with post test (Tukey's Multiple Compari-
son Test). Values of P < 0.05 were considered statistically
significant.
Results
Effect of the LTB4-loaded MS administration on leukocyte 
infiltration into the lungs and leukocyte-endothelial cell 
interactions
To investigate whether microspheres could release the
encapsulated LTB4 during days, we assessed the leukocyte
infiltration into the lung parenchyma of 5-LO knockout
(5-LO-/-) mice submitted to the evaluated administra-
tions. In this context, LTB4-loaded MS provoked a greater
BMC Immunology 2008, 9:36 http://www.biomedcentral.com/1471-2172/9/36
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leukocyte infiltration into the lung parenchyma when
compared to the other groups assayed (Fig. 1D). Intravital
microscopy study was chosen to examine leukocyte-
endothelial cell interactions in the mice cremasteric
microcirculation. Figure 2 shows the effect of LTB4-loaded
MS on leukocyte responses. After 4 h intraescrotal injec-
tion of 0.1 ml of 0.05 μg/kg LPS (used as control), signif-
icant increases in leukocyte rolling flux (91.0 ± 7.8 vs.
46.0 ± 1.7 cells/min), adhesion (14.0 ± 2.8 vs. 1.0 ± 1.4
cells per 100 μm vessel) and emigration (20.5 ± 0.7 vs. 1.3
± 1.0 cells per field), and significant decreases in leukocyte
rolling velocity (8.4 ± 1.9 vs. 25.9 ± 3.3 μm/s) were
detected vs. values obtained in the saline treated animals.
Injection of LTB4-loaded MS significantly increased leuko-
cyte rolling flux (72.0 ± 5.2 vs. 46.0 ± 1.7 and 45.0 ± 7.07
cells/min), adhesion (4.5 ± 0.7 vs. 1.2 ± 0.5 and 1.5 ± 0.7
cells per 100 μm vessel) and emigration (7.3 ± 0.6 vs. 1.3
± 1.0 and 2.5 ± 0.7 cells per field), and decreased the leu-
kocyte rolling velocity (14.1 ± 0.9 vs. 25.9 ± 3.3 and 30.4
± 7.9 μm/s) vs. values obtained in mice injected with
saline and unloaded MS, respectively. None of these treat-
ments had significant effects on wall shear rate (Table 1).
LTB4-loaded MS increase NO generation in HUVECs and 
HUAECs
Production of NO by human endothelial cells was quan-
tified as described. In HUVECs, LTB4-loaded MS signifi-
cantly increased nitrite levels when compared to the other
stimuli (Fig. 3A). LTB4 in solution was also able to pro-
mote NO release although in moderate amounts. In con-
trast, the unloaded MS caused no significant increase in
NO2- production. On the other hand, the assay performed
in HUAECs revealed that only LTB4-loaded MS could sig-
nificantly increase the levels of nitrite (Fig. 3B).
Table 1: Hemodynamic parameters in the mice cremasteric microcirculation
Saline LPS Unloaded MS LTB4-loaded MS LTB4 solution
Venular diameter (μm) 26.5 ± 4.7 28.0 ± 3.4 19.5 ± 1.5 17.3 ± 1.2 20.0 ± 2
Venular shear rate (s-1) 618.7 ± 6.2 784.0 ± 1.3 843.8 ± 108.5 670.2 ± 65 879.0 ± 143.7
Parameters (mean ± SEM, in C57BL/6J mice used for intravital microscopy studies) were measured 4 h after the intraescrotal injection of saline, LPS 
(0.05 μg/kg), unloaded or LTB4-loaded MS (1 mg/ml) and LTB4 solution (200 ng/ml); (n = 4), from two different experiments.
LTB4-loaded MS provoke leukocyte infiltration in the lung parenchymaFigure 1
LTB4-loaded MS provoke leukocyte infiltration in the lung parenchyma. The lungs were removed on day 7 after the 
administrations, fixed and paraffin-embedded, followed by staining with HE. Lung sections are representative of three experi-
ments with 5-LO-/- mice (5 animals each group) that received (A) PBS; (B) LTB4 in solution (3 × 10-8 M); (C) unloaded MS and 
(D) LTB4-loaded MS (5 × 10-7 M or 160 ng/ml). Magnifications of each section: ×50 and ×400.
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Engulfed LTB4-loaded MS increase NO generation and 
PPARα expression in murine macrophages
We investigated nitrites levels produced by murine macro-
phages as a prediction of NO generation. High levels of
nitrites were only achieved when the cells were stimulated
with LTB4-loaded MS both in the presence or absence of
CP 105,696 (Fig. 4A). Moreover, a further increase in
nitrites production was detected when the LTB4-loaded
MS were co-incubated with the BLT1 antagonist (CP
105,696) (Fig. 4A). Conversely, LTB4 in solution with or
without antagonist had no effect on NO release. To assess
the expression of the nuclear receptors and their possible
activation under the effect of LTB4-loaded MS, we detected
PPARα (molecular weight of approximately 52 kDa) in
Effect of LTB4 in solution and released from PLGA microspheres (LTB4-loaded MS) on leukocyte rolling flux (A), rolling velocity (B), adhesion (C) and emigration (D) in mice cremaster muscl  postcapill ry venulesFigure 2
Effect of LTB4 in solution and released from PLGA microspheres (LTB4-loaded MS) on leukocyte rolling flux 
(A), rolling velocity (B), adhesion (C) and emigration (D) in mice cremaster muscle postcapillary venules. 
Parameters were measured 4 hours after the intraescrotal administration of saline (negative control), LPS (positive control, 
0.05 μg/kg), unloaded and LTB4-loaded MS (1 mg/ml) and LTB4 in solution (200 ng/ml). Results are mean ± SEM (n = 4). *P < 
0.05, **P < 0.01, ***P < 0.001, LTB4-loaded MS compared to saline group. # P < 0.05, ## P < 0.01 and &P < 0.05, LTB4-loaded 
MS compared to unloaded MS and LTB4 solution, respectively.
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murine macrophages by Western Blot analysis. Treatment
with LTB4 in solution increased PPARα expression moder-
ately and this effect was blocked by pre-treatment of the
cells with the BLT1 antagonist (CP 105,696) (Fig. 4B).
However, when the cells were stimulated with LTB4-
loaded MS, a further increase in PPARα expression was
noted. Interestingly, a marked and significant increase in
PPARα expression was also observed when the cells were
stimulated with LTB4-loaded MS in the presence of the
antagonist, especially when compared to that observed for
the treatments with LTB4 solution + CP and LTB4-loaded
MS.
LTB4 released from microspheres increases MCP-1 
production by human endothelial cells
To evaluate LTB4-induced chemokine release at the cellu-
lar level, we used cultures of HUVECs and HUAECs. The
amount of the chemokine released in the culture medium
was determined by ELISA. In HUVECs, MCP-1 levels were
significantly increased after 4 h stimulation with LTB4-
loaded MS but not when the cells were stimulated with
LTB4 in solution (Fig. 5A). In HUAECs, unloaded, LTB4-
loaded MS and LTB4 in solution were able to increase
MCP-1 contents in the supernatants investigated (Fig. 5B).
Both in HUVECs and HUAECs assay, LTB4-loaded MS
were able to increase significantly MCP-1 levels when
compared to LTB4 solution stimulus.
Discussion
LTB4 is a classical chemoattractant agent that plays a cru-
cial role in multiple inflammatory diseases. It promotes
leukocytes adhesion and diapedesis through the endothe-
lial cell barrier. Furthermore, LTB4 also induces chemo-
taxis and proliferation of human coronary artery [21].
However, the molecular mechanisms by which LTB4
induces transendothelial migration of leukocytes are not
completely elucidated although it seems to be involved
soluble factors as well as both leukocyte and endothelial
cell adhesion molecules [25]. Direct effects of LTB4 on
endothelial cells have also been discussed, although these
cells have shown a weak reaction to this mediator [35,36].
First, in this study, we investigated whether the proposed
microspheres could release the encapsulated LTB4 during
days and stimulate cells recruitment into the lung paren-
chyma. For this purpose, we performed an assay using 5-
LO-/- mice since they do not have endogenous synthesis of
leukotrienes and only exogenous LTB4 employed could
exert its biological activity. Animals that received LTB4-
loaded MS displayed greater leukocyte infiltration in the
lung parenchyma compared to PBS, LTB4 in solution or
unloaded MS groups, demonstrating that the encapsula-
tion method preserved the biological activity of the medi-
ator. Although LTB4-loaded MS have recruited more
leukocytes to the lung parenchyma than the other stimuli,
the unloaded MS also provoked a marked cell infiltration.
This fact can be due to the particle size (<10 μm)
employed in our study since the microspheres will be
preferentially engulfed by phagocytes, especially alveolar
macrophages present in the lungs. The cell activation pro-
voked by the engulfment of the microspheres suggests
NO production by HUVECs (A) and HUAECs (B)Figure 3
NO production by HUVECs (A) and HUAECs (B). 
NO2- levels were quantified by Griess reaction in the super-
natants of cells incubated with medium, 1 mg of unloaded and 
LTB4-loaded MS or LTB4 in solution (200 ng/ml). Results are 
expressed as mean ± SEM (n = 3); *P < 0.05, ***P < 0.001, 
LTB4-loaded MS compared to control (medium). ###P < 
0.001 and &P < 0.05, &&&P < 0.001, LTB4-loaded MS com-
pared to unloaded MS and LTB4 solution, respectively.
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that other chemotactic factors or cytokines released during
the particles' delivery could increase cell infiltration in the
lungs. Regarding the desired pattern of cell activation, the
unloaded or LTB4-loaded MS could be useful to stimulate
the immune response against intracellular pathogens.
Based on these different profiles of leukocyte infiltration
provoked by the employment of the microspheres, our
histological sections showed marked differences on the
cell recruitment to the lungs, especially on day 7 after
administrations (Fig. 1). In this regard, we previously
demonstrated that the LTB4 released from microspheres
recruited high numbers of mononuclear cells and neu-
trophils to the bronchoalveolar space of 5-LO-/- mice [27].
Also, we conducted lung sections earlier than day 7 (days
1 and 4) but no significant leukocyte infiltration was
achieved. Our findings suggest that the extended released
of LTB4 from microspheres was able to activate and induce
lung cells to generate chemotactic agents, reflected by the
greater leukocyte infiltration into the parenchyma lung.
These results corroborate the idea that cell migration phe-
nomenon is strongly stimulus-dependent since exoge-
nous LTB4 could prime the cells to chemotactic mediators
release and recruit them to the bronchoalveolar space or
lung parenchyma.
We have demonstrated that LTB4 released from micro-
spheres but not LTB4 in solution can cause leukocyte-
endothelial cell interactions within the mice cremasteric
microcirculation, as demonstrated by intravital micros-
copy studies (Fig. 2). These results confirm that the encap-
sulation of the lipid mediator is an important strategy to
preserve its biological activity, constituting a tool to stim-
ulate cells. We can suggest that the microspheres might
protect the LTB4 molecule against degradation and/or
even facilitate its interaction with either the endothelium
or the leukocytes.
In order to extend these findings to humans, we measured
the production of nitrites and MCP-1 in response to LTB4-
loaded MS both in HUVECs and HUAECs. In this context,
different studies have shown that LTB4 promotes nitrites,
presumably reflecting NO generation, and MCP-1 release
in HUVECs and this effect is enhanced when the endothe-
lial cells are preincubated with LPS, presumably via a
functional up-regulation of BLT1 receptor [20]. In con-
trast, the amounts of BLT2 mRNA gradually decreased
when the cells were incubated with LTB4. In our study,
when human endothelial cells were stimulated with LTB4-
loaded MS it was detected a massive release of nitrites and
NO production (A) and PPARα expression (B) by peritoneal macrophages after 4 hours incubation in RPMI mediumFigure 4
NO production (A) and PPARα expression (B) by peritoneal macrophages after 4 hours incubation in RPMI 
medium. Peritoneal macrophages were incubated for 4 h with LTB4 in solution (5 × 10-8 M) with or without a specific BLT1 
receptor antagonist (CP105,696). Similarly, cells were incubated with unloaded or LTB4-loaded MS (1 mg/ml) in absence or 
presence of CP105,696. (A) The nitrites levels were quantified by Griess reaction in the supernatants of the cells. The data are 
expressed as means ± the SEM (n = 3); **P < 0.01, ***P < 0.001, when compared to control (medium). ##P < 0.01, LTB4-loaded 
MS compared to LTB4-loaded MS + CP. (B) Western blot analysis for PPARα was performed as previously described in the 
Materials and Methods Section. Densitometric measurements show representative data of three separated experiments (mean 
± SEM). **P < 0.01, LTB4-loaded MS + CP compared to LTB4 solution + CP. ##P < 0.01, LTB4-loaded MS + CP compared to 
LTB4-loaded MS.
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MCP-1 compared to those obtained when LTB4 is in solu-
tion form. This fact demonstrating the role of LTB4-loaded
MS in increasing a chemotactic protein (as detected by
MCP-1 levels) corroborates the results obtained from
intravital microscopy study where we could observe more
leukocytes adhered and emigrated to the cremasteric tis-
sue after the administration of those microspheres. There-
fore, our findings add further support to the hypothesis
that microspheres protect LTB4 molecule from its metabo-
lism, especially in this protocol in which a 4 h time period
was chosen to carry out the different assays. Nevertheless,
it is likely that both forms of LTB4 exert similar effects
under acute conditions (1 h). Although unloaded MS
have induced MCP-1 release by HUAECs (Fig. 5B), this
fact can be due to the physical interactions between cell
surface and the polymer employed to do the micro-
spheres. Our results suggest that LTB4-loaded MS
employed in the assays can stimulate the cells and induce
a different pattern of inflammatory response compared to
the mediator in solution.
In order to get more conclusive data, we also compared
the effect of LTB4 in solution with that released from
microspheres on NO production by mice peritoneal mac-
rophages, in the presence of a specific BLT1 receptor
antagonist, CP 105,696 (Fig. 4A). In this in vitro system,
only LTB4-loaded MS caused a significant nitrites release
whereas LTB4 in solution did not display any effect. Inter-
estingly, when BLT1 receptors were blocked with CP
105,696 an enhanced and significant response was
observed. This fact can be due to the different mechanisms
of cell activation conferred by LTB4 in solution or released
from MS. It is also likely that LTB4 released from engulfed
MS could exert its activity inside the cell nucleus, where it
can bind to specific receptors, whereas exogenous LTB4 in
solution binds only to specific BLTs membrane receptors.
In this context, it is known that LTB4 is a natural ligand for
PPARα, a subtype of a family of PPARs. These transcrip-
tion factors regulate gene expression of enzymes associ-
ated with lipid homeostasis and affect the duration of an
inflammatory response induced by LTB4 [12]. Although
the majority of studies have indicated an anti-inflamma-
tory role of PPARα ligands, an increase in the neutrophil
chemoattractant IL-8 and the MCP-1 levels have also been
observed in endothelial cells [37]. In addition, the PPARα
ligand fenofibrate was demonstrated to enhance nitric
oxide synthase (NOS) expression and activity in isolated
endothelial cells [38]. Also, it is important to note that
some studies report that PPARγ has no anti-inflammatory
activity or might indeed exert a proinflammatory response
[39]. With this regard, as proposed in this study, the LTB4
binding to nuclear receptors without previous interaction
with its membrane receptors (BLTs) results in an increase
of PPARα expression (Fig. 4B) and possibly activates the
inflammatory genes to produce NO, MCP-1 and other
inflammatory mediators. A recent published work by our
group regarding a phagocytosis' assay of LTB4-loaded MS
[27] showed that encapsulated LTB4 was able to increase
the number of mice peritoneal macrophages that contain
microspheres and also the amount of them that were
engulfed. These previous findings involving cell activation
MCP-1 levels in the supernatant of HUVECS (A) and HUAECs (B)Figure 5
MCP-1 levels in the supernatant of HUVECS (A) and 
HUAECs (B). Cells were incubated with 1 mg of unloaded, 
LTB4-loaded MS or LTB4 in solution (200 ng/ml). MCP-1 con-
tent was determined by ELISA. Results are expressed as 
mean ± SEM (n = 3); **P < 0.01, ***P < 0.001, LTB4-loaded 
MS compared to control (medium). ###P < 0.001 and &&&P 
< 0.001, LTB4-loaded MS compared to unloaded MS and 
LTB4 solution, respectively.
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by the uptake of LTB4-loaded MS support our recent
results showing that macrophages activation induced by
LTB4-loaded MS can be more persistent than that with the
mediator in solution.
Conclusion
As reported in this study, the employment of LTB4-loaded
MS seems to preserve the biological activity of the inflam-
matory lipid mediator as demonstrated by intravital
microscopy studies as well as by in vitro assays using
murine peritoneal macrophages and human endothelial
cells. Therefore, these findings may contribute to the bet-
ter understanding of the different pattern of cell activation
induced by the delivery of the LTB4 to cell cytoplasm or
nucleus and maybe these microspheres can constitute an
alternative therapy for the control of different infectious
diseases.
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